People with short bowel syndrome (SBS) need a high-touch approach to be effectively managed. Option Care Enterprises, Inc. has a nutritional support team providing clinical interventions, and it recently released a study showing that this approach can save millions of dollars in costs per year. The home and alternate site infusion provider also unveiled a study revealing the benefits of proactively screening for appropriate dosing before people receive Gattex (teduglutide).
To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.